Gómez-Aguilera, M.; Manzanares-MartÃn, B.; Cebrián-Aranda, A.; RodrÃguez-Ariza, A.; González-Fernández, R.; del Puerto-Nevado, L.; GarcÃa-Foncillas, J.; Aranda, E.
Immune Modulation Through KIR–HLA Interactions Influences Cetuximab Efficacy in Colorectal Cancer. Int. J. Mol. Sci. 2025, 26, 8062.
https://doi.org/10.3390/ijms26168062
AMA Style
Gómez-Aguilera M, Manzanares-MartÃn B, Cebrián-Aranda A, RodrÃguez-Ariza A, González-Fernández R, del Puerto-Nevado L, GarcÃa-Foncillas J, Aranda E.
Immune Modulation Through KIR–HLA Interactions Influences Cetuximab Efficacy in Colorectal Cancer. International Journal of Molecular Sciences. 2025; 26(16):8062.
https://doi.org/10.3390/ijms26168062
Chicago/Turabian Style
Gómez-Aguilera, MarÃa, Bárbara Manzanares-MartÃn, Arancha Cebrián-Aranda, Antonio RodrÃguez-Ariza, Rafael González-Fernández, Laura del Puerto-Nevado, Jesús GarcÃa-Foncillas, and Enrique Aranda.
2025. "Immune Modulation Through KIR–HLA Interactions Influences Cetuximab Efficacy in Colorectal Cancer" International Journal of Molecular Sciences 26, no. 16: 8062.
https://doi.org/10.3390/ijms26168062
APA Style
Gómez-Aguilera, M., Manzanares-MartÃn, B., Cebrián-Aranda, A., RodrÃguez-Ariza, A., González-Fernández, R., del Puerto-Nevado, L., GarcÃa-Foncillas, J., & Aranda, E.
(2025). Immune Modulation Through KIR–HLA Interactions Influences Cetuximab Efficacy in Colorectal Cancer. International Journal of Molecular Sciences, 26(16), 8062.
https://doi.org/10.3390/ijms26168062